Significant Ownership of Camber Capital Management LP

Signature - Title
/s/ Sean George - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Camber Capital Management LP.

Follow Filing Activity

Follow Camber Capital Management LP and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Significant Ownership of Camber Capital Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTCT PTC THERAPEUTICS, INC. Common Stock $0.001 par value per share 4.2% $158,464,000 3,200,000 Camber Capital Management LP 31 Dec 2024
INGN Inogen Inc Common Stock, $0.001 par value 3.7% $7,088,250 975,000 Camber Capital Management LP 31 Mar 2025
MYGN MYRIAD GENETICS INC Common Stock, par value $0.01 per share 3.4% $22,320,000 3,100,000 Camber Capital Management LP 31 Dec 2024
BKD Brookdale Senior Living Inc. Common Stock, $0.01 par value 2.7% $39,375,000 -$68,786,708 6,250,000 -64% Camber Capital Management LP 31 Mar 2025
OSUR ORASURE TECHNOLOGIES INC Common Stock, $0.000001 par value 1.2% $2,727,000 900,000 Camber Capital Management LP 31 Mar 2025
ZIMV ZimVie Inc. Common Stock, par value $0.01 per share 0% $0 -$30,112,000 0 -100% Camber Capital Management LP 21 Jul 2025
PBYI PUMA BIOTECHNOLOGY, INC. Common Stock, par value $0.0001 per share 0% $0 0 Camber Capital Management LP 31 Dec 2024
SLDB Solid Biosciences Inc. Common Stock,$0.001 par value per share 0% $0 0 Camber Capital Management LP 31 Dec 2024

Schedules 13D/G Reported by Camber Capital Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .